Sjogren's Syndrome and TAM Receptors: A Possible Contribution to Disease Onset
Overview
Affiliations
Sjogren's syndrome (SS) is a chronic, progressive autoimmune disease featuring both organ-specific and systemic manifestations, the most frequent being dry mouth and dry eyes resulting from lymphocytic infiltration into the salivary and lacrimal glands. Like the related autoimmune disease systemic lupus erythematosus (SLE), SS patients and mouse models display accumulation of apoptotic cells and a Type I interferon (IFN) signature. Receptor tyrosine kinases (RTKs) of the Tyro3, Axl, and Mer (TAM) family are present on the surface of macrophages and dendritic cells and participate in phagocytosis of apoptotic cells (efferocytosis) and inhibition of Type I IFN signaling. This review examines the relationship between TAM receptor dysfunction and SS and explores the potential contributions of TAM defects on macrophages to SS development.
Sjögren's Disease and Gastroesophageal Reflux Disease: What Is Their Evidence-Based Link?.
Mieliauskaite D, Kontenis V Medicina (Kaunas). 2024; 60(11).
PMID: 39597079 PMC: 11596513. DOI: 10.3390/medicina60111894.
Advances in cellular and molecular pathways of salivary gland damage in Sjögren's syndrome.
Qi W, Tian J, Wang G, Yan Y, Wang T, Wei Y Front Immunol. 2024; 15:1405126.
PMID: 39050857 PMC: 11266040. DOI: 10.3389/fimmu.2024.1405126.
Wang R, Yang Y, Liu X, Lei L, Qi X Cent Eur J Immunol. 2023; 48(2):144-149.
PMID: 37692029 PMC: 10485687. DOI: 10.5114/ceji.2023.127536.
Analysis of the saliva metabolic signature in patients with primary Sjögren's syndrome.
Li Z, Mu Y, Guo C, You X, Liu X, Li Q PLoS One. 2022; 17(6):e0269275.
PMID: 35653354 PMC: 9162338. DOI: 10.1371/journal.pone.0269275.
Witas R, Shen Y, Nguyen C Sci Rep. 2022; 12(1):8593.
PMID: 35597820 PMC: 9124194. DOI: 10.1038/s41598-022-12608-4.